Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Bronchodilators

  • Breaking microgram barrier to conduct dose ranging studies with long acting bronchodilators from a novel cosuspension metered dose inhaler product platform
    Vidya Joshi, Brian Noga, David Lechuga-Ballesteros, Robert Schultz, Harris Cummings, Michael Golden, Chad Orevillo, Colin Reisner, Sarvajna Dwivedi
    European Respiratory Journal Sep 2012, 40 (Suppl 56) P2150;
  • How frequent is bronchodilator reversibility in patients with stable asthma bronchiale and chronic obstructive lung disease (COPD) receiving maintenance therapy?
    Veronika Muller, Gabriella Galffy, Marta Orosz, Zsuzsanna Kovats, Gyorgy Losonczy, Lilla Tamasi
    European Respiratory Journal Sep 2012, 40 (Suppl 56) P2162;
  • Preference, satisfaction and critical errors with Genuair® and HandiHaler® in patients with COPD
    Job van der Palen, Thomas Ginko, Axel Kroker, Paul van der Valk, Martijn Goosens, Laura Padulles, Beatriz Seoane, Ludmyla Rekeda, Esther Garcia Gil
    European Respiratory Journal Sep 2012, 40 (Suppl 56) P2177;
  • Tiotropium provides sustained bronchodilation in asthmatics with persistent airflow obstruction uncontrolled despite treatment in accordance with guidelines
    Huib Kerstjens, Pierluigi Paggiaro, Mark Vandewalker, Ekkehard Beck, Michael Engel, Ralf Sigmund, Wolfgang Seibold, Petra Moroni-Zentgraf, Eric Bateman
    European Respiratory Journal Sep 2012, 40 (Suppl 56) P2187;
  • The effects of sildenafil on lung function in COPD
    Andrew Goudie, Pippa Hopkinson, William Anderson, Brian Lipworth, Allan Struthers
    European Respiratory Journal Sep 2012, 40 (Suppl 56) P2188;
  • Tiotropium enhances the inhibitory effect of the long acting β2-agonist olodaterol on the release of IL-6 and IL8 by primary human lung fibroblasts of asthma patients
    Luigi Costa, Michael Roth, Michael Tamm, Pieter Borger
    European Respiratory Journal Sep 2012, 40 (Suppl 56) P2184;
  • Safety and efficacy of NVA237 once daily in Japanese patients: The GLOW4 trial
    Mitsuaki Sekiya, Tomotaka Kawayama, Yoshinosuke Fukuchi, Yota Takahashi, Tetsuya Kaiso, Kimitoshi Ikeda, Tim Overend, Donald Banerji
    European Respiratory Journal Sep 2012, 40 (Suppl 56) P2103;
  • In vitro evaluation of a new spacer for pMDI and nebulizers in mechanical ventilation
    Nabile Boukhettala, Maria Cabrera, Patrice Diot, Thierry Porée, Laurent Vecellio
    European Respiratory Journal Sep 2012, 40 (Suppl 56) P2012;
  • Onset of bronchodilation with fluticasone/formoterol versus fluticasone/salmeterol
    Guy Brusselle, René Aalbers, Tammy McIver, Birgit Grothe, Anna Bodzenta-Lukaszyk
    European Respiratory Journal Sep 2012, 40 (Suppl 56) P2082;
  • Patient characteristics that can predict response to omalizumab an (anti-IgE antibody) for achieving better control of asthmatic patients
    Nancy Abdelaty
    European Respiratory Journal Sep 2012, 40 (Suppl 56) P2086;

Pages

  • Previous
  • Next
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • Acute lung injury and critical care (82)
  • Asthma and allergy (662)
  • CF and non-CF bronchiectasis (278)
  • COPD and smoking (909)
  • Epidemiology, occupational and environmental lung disease (214)
  • Genetics (60)
  • Interstitial and orphan lung disease (499)
  • Lung biology and experimental studies (318)
  • Lung cancer (282)
  • Lung imaging (45)
  • Lung structure and function (303)
  • Mechanisms of lung disease (145)
  • Paediatric pulmonology (394)
  • Pulmonary pharmacology and therapeutics (141)
  • Pulmonary vascular disease (523)
  • Respiratory clinical practice (171)
  • Respiratory infections and tuberculosis (973)
  • Sleep medicine (267)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • Pulsus paradoxus
  • ERS/ATS technical standard on interpretive strategies for routine lung function tests
  • European Respiratory Society guidelines for the diagnosis of asthma in adults
  • The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
  • ERS clinical practice guidelines on treatment of sarcoidosis
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society